| Literature DB >> 31769085 |
Kanna Adachi1, Tomoshi Yamada2, Hayate Ishizuka1, Mana Oki1, Shunsuke Tsunogae2, Noriko Shimada2, Osamu Chiba2, Tatsuya Orihara1, Masafumi Hidaka2, Takatsugu Hirokawa3,4,5, Minami Odagi1, Keiichi Konoki2, Mari Yotsu-Yamashita2, Kazuo Nagasawa1.
Abstract
A novel series of C12-keto-type saxitoxin (STX) derivatives bearing an unusual nonhydrated form of the ketone at C12 has been synthesized, and their NaV -inhibitory activity has been evaluated in a cell-based assay as well as whole-cell patch-clamp recording. Among these compounds, 11-benzylidene STX (3 a) showed potent inhibitory activity against neuroblastoma Neuro 2A in both cell-based and electrophysiological analyses, with EC50 and IC50 values of 8.5 and 30.7 nm, respectively. Interestingly, the compound showed potent inhibitory activity against tetrodotoxin-resistant subtype of NaV 1.5, with an IC50 value of 94.1 nm. Derivatives 3 a-d and 3 f showed low recovery rates from NaV 1.2 subtype (ca 45-79 %) compared to natural dcSTX (2), strongly suggesting an irreversible mode of interaction. We propose an interaction model for the C12-keto derivatives with NaV in which the enone moiety in the STX derivatives 3 works as Michael acceptor for the carboxylate of Asp1717 .Entities:
Keywords: drug discovery; inhibitors; ion channels; membrane proteins; protein structures
Mesh:
Substances:
Year: 2020 PMID: 31769085 DOI: 10.1002/chem.201904184
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236